<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene P9L;D22Y;Q27*;T32I;Q57H;I82T;E96Q;P129L;C136del;N137del;D138del;P139del;F140del;L141del;G142del;V143del;Y144del;V149A;R190S;T205I;I210T;E272G;P323L;R346S;E378Q.;S386F;N394S;R401H;Y449N;F490R;T492I;N501Y;D614G;P681H;T859N;D936H;L1301F;A1537A literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.P9L;D22Y;Q27*;T32I;Q57H;I82T;E96Q;P129L;C136_N137_D138_P139_F140_L141_G142_V143_Y144del;V149A;R190S;T205I;I210T;E272G;P323L;R346S;E378Q.;S386F;N394S;R401H;Y449N;F490R;T492I;N501Y;D614G;P681H;T859N;D936H;L1301F;A1537A</span> literature reference collection</h1>
<div class="effect_section"><h2 id="vaccinee_plasma_binding">Vaccinee plasma binding</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Out of 10 individuals with 2 doses of the BNT162b2/BNT162b2 vaccine, neutralizing titer in B.1.640.2 variant was ~1000x folds more significant in 8 individuals.<br/> (<a href="https://doi.org/10.1038/s41423-022-00870-5" class="lit_link">Arora et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Out of 10 individuals with 3 doses of the BNT162b2/BNT162b2/BNT162b2 vaccine had a neutralizing titer in B.1.640.2 variant was ~5.6x folds more significant in 9  individuals.<br/> (<a href="https://doi.org/10.1038/s41423-022-00870-5" class="lit_link">Arora et al. (2022)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
